Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
The Annals of Thoracic Surgery
|
April 22, 2026
Acute Distal Limb Ischemia after Large-Bore Arterial Access: An Expert Review and Consensus Recommendations
Raghad Said, Michael P W Grocott, Courtney Maxey-Jones, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2016
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine
Kelly E Huibregtse, Kieuhoa T Vo, Steven G DuBois, et al.
Pediatric Blood & Cancer
|
May 23, 2014
Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study
Brian Weiss, Brigitte C Widemann, Pamela Wolters, et al.
BMJ Quality & Safety
|
September 6, 2015
Sustained reductions in time to antibiotic delivery in febrile immunocompromised children: results of a quality improvement collaborative
Christopher E Dandoy, Selena Hariharan, Brian Weiss, et al.
Pediatrics
|
November 12, 2014
A team-based approach to reducing cardiac monitor alarms
Christopher E Dandoy, Stella M Davies, Laura Flesch, et al.
Neuro-Oncology
|
October 16, 2014
Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study
Brian Weiss, Brigitte C Widemann, Pamela Wolters, et al.
Plos Genetics
|
December 21, 2016
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
Olivia M Padovan-Merhar, Pichai Raman, Irina Ostrovnaya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2012
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial
Katherine K Matthay, Brian Weiss, Judith G Villablanca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study
Gregory A Yanik, Judith G Villablanca, John M Maris, et al.
The New England Journal of Medicine
|
December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
The Annals of Thoracic Surgery
|
April 22, 2026
Acute Distal Limb Ischemia after Large-Bore Arterial Access: An Expert Review and Consensus Recommendations
Raghad Said, Michael P W Grocott, Courtney Maxey-Jones, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2016
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine
Kelly E Huibregtse, Kieuhoa T Vo, Steven G DuBois, et al.
Pediatric Blood & Cancer
|
May 23, 2014
Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study
Brian Weiss, Brigitte C Widemann, Pamela Wolters, et al.
BMJ Quality & Safety
|
September 6, 2015
Sustained reductions in time to antibiotic delivery in febrile immunocompromised children: results of a quality improvement collaborative
Christopher E Dandoy, Selena Hariharan, Brian Weiss, et al.
Pediatrics
|
November 12, 2014
A team-based approach to reducing cardiac monitor alarms
Christopher E Dandoy, Stella M Davies, Laura Flesch, et al.
Neuro-Oncology
|
October 16, 2014
Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study
Brian Weiss, Brigitte C Widemann, Pamela Wolters, et al.
Plos Genetics
|
December 21, 2016
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
Olivia M Padovan-Merhar, Pichai Raman, Irina Ostrovnaya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2012
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial
Katherine K Matthay, Brian Weiss, Judith G Villablanca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study
Gregory A Yanik, Judith G Villablanca, John M Maris, et al.
The New England Journal of Medicine
|
December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Page
of 5